Focal Healthcare’s Fusion Bx 2.0 Targeted Prostate Biopsy Solution Receives CE Mark

Fusion Bx™ 2.0 MRI/Ultrasound fusion technology to provide targeted prostate biopsies across Europe TORONTO, CANADA – Focal Healthcare, an innovator of image-guided prostate cancer technology, announced it has received CE Mark for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining information from multiparametric MRI (mpMRI) with a semi-robotic arm and user-friendly interface, the […]

Fusion Bx to be Featured at UAA2019

Focal Healthcare will be taking part in the 17th Urological Association of Asia Congress at the Kuala Lumpur Convention Centre in Malaysia, on August 7-10. Our Fusion Bx prostate fusion biopsy system will be featured in the Sonacare booth – G02. Stop by to learn about MRI-targeted prostate biopsy and to see the many benefits […]

Focal Healthcare to Exhibit at AUI 2019 Conference

Focal Healthcare will be taking part in the 2019 Advanced Urology Institute Annual Conference at the Eau Palm Beach Resort and Spa in Manalapan, FL on July 19-21. Be sure to visit us for a hands-on demonstration of our Fusion Bx prostate fusion biopsy device. Moreover, hear from one of AUI’s very own practices about […]

Learn About MRI-Targeted Prostate Biopsies at CUA 2019

Join us at the CUA 2019 Annual Meeting happening on June 29 – July 1 in Quebec City to see the latest innovations in MRI-targeted prostate biopsy. Our Fusion Bx prostate fusion biopsy platform is the only MRI-ultrasound fusion biopsy device that is designed, engineered and manufactured entirely here in Canada. With a semi-robotic arm that maintains the […]

Focal Healthcare will be at the Prostate Imaging & Focal Therapy Masterclass

Prostate Imaging & Focal Therapy Masterclass 2019 Focal Healthcare will be participating in the 2019 Prostate Imaging & Focal Therapy Masterclass taking place at the Sir Alexander Fleming Building in London. Join us on April 5-6 for the 2 day masterclass happening in the South Kensington Campus. The faculty’s teaching objectives over this two day […]

Focal Healthcare is Exhibiting at EAU19 for the First Time – Stand C44

EAU19 Focal Healthcare will be exhibiting at the 34th Annual EAU Congress in Barcelona on March 16-18, 2019 at the Fira Gran Via. Visit us at stand C44, Hall 8 to get a demonstration of our Fusion Bx 2.0 prostate fusion biopsy system. The EU is now seeing a fundamental shift in prostate cancer diagnosis […]

Focal Healthcare is Exhibiting at the CUOS – Booth #305

Canadian Uro-Oncology Summit 2019 Focal Healthcare will be exhibiting at the first annual meeting for Uro-oncology specialists, Canadian Uro-Oncology Summit (CUOS) on Jan 10-12, 2019 at the Westin Harbour Castle Hotel in Toronto, ON. Visit us at booth 305 in the Harbour Ballroom to get a hands-on demo of our recently launched Fusion Bx 2.0 […]

Focal Healthcare Receives FDA 510(k) Clearance and Health Canada Approval for Fusion Bx™ 2.0

Fusion Bx™ 2.0 leverages MRI/Ultrasound fusion technology to provide targeted prostate biopsies TORONTO, CANADA – Focal Healthcare, an innovator of image-guided prostate cancer technology, announced it has received both FDA 510(k) clearance and Health Canada approval for its Fusion Bx™ 2.0 prostate biopsy solution. The Fusion Bx 2.0 is now available for sale in the United […]

Focal Healthcare is Attending the CUA 2018 Meeting – Booth 111

73rd Canadian Urological Association Annual Meeting Focal Healthcare is attending the Canadian Urological Association 2018 Meeting – Booth 111 – June 23 – 26, 2018 in Halifax, Nova Scotia.  Please stop by our booth to experience our next generation Fusion Bx firsthand.   Meeting Overview The central scientific theme is evolving therapies and the future of […]